Petros Pharmaceuticals, Inc. (PTPI)
NASDAQ: PTPI · Real-Time Price · USD
0.294
-0.018 (-5.67%)
At close: Dec 20, 2024, 4:00 PM
0.260
-0.034 (-11.68%)
After-hours: Dec 20, 2024, 7:59 PM EST
Petros Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Revenue | 4.02 | 5.82 | 5.99 | 7.81 | 9.56 | 15.58 | Upgrade
|
| Revenue Growth (YoY) | -42.41% | -2.83% | -23.29% | -18.29% | -38.63% | 10.86% | Upgrade
|
| Cost of Revenue | 1.11 | 1.63 | 2.29 | 1.6 | 4.05 | 7.43 | Upgrade
|
| Gross Profit | 2.92 | 4.19 | 3.7 | 6.21 | 5.51 | 8.15 | Upgrade
|
| Selling, General & Admin | 10.18 | 9.26 | 12.21 | 15.59 | 15.67 | 19.73 | Upgrade
|
| Research & Development | 3.35 | 2.41 | 1.74 | 1.79 | 0.46 | - | Upgrade
|
| Operating Expenses | 16.5 | 14.95 | 19.55 | 24.26 | 22.8 | 25.02 | Upgrade
|
| Operating Income | -13.59 | -10.76 | -15.85 | -18.05 | -17.28 | -16.87 | Upgrade
|
| Interest Expense | -0.52 | -0.54 | -0.6 | -0.37 | -3.05 | -13.84 | Upgrade
|
| Interest & Investment Income | 0.57 | 0.52 | 0.01 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 6.22 | 0.03 | - | - | -1.68 | - | Upgrade
|
| EBT Excluding Unusual Items | -7.32 | -10.75 | -16.43 | -18.42 | -22.01 | -30.71 | Upgrade
|
| Impairment of Goodwill | - | - | - | - | - | -2.44 | Upgrade
|
| Asset Writedown | - | - | -7.46 | - | - | - | Upgrade
|
| Other Unusual Items | 2.59 | 2.59 | 3.85 | 9.43 | - | - | Upgrade
|
| Pretax Income | -4.73 | -8.16 | -20.04 | -8.99 | -22.01 | -33.16 | Upgrade
|
| Income Tax Expense | - | - | - | - | -1.43 | -0.65 | Upgrade
|
| Net Income | -4.73 | -8.16 | -20.04 | -8.99 | -20.59 | -32.51 | Upgrade
|
| Preferred Dividends & Other Adjustments | 15.12 | 5.65 | - | - | - | - | Upgrade
|
| Net Income to Common | -19.85 | -13.81 | -20.04 | -8.99 | -20.59 | -32.51 | Upgrade
|
| Shares Outstanding (Basic) | 6 | 2 | 2 | 1 | 1 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 6 | 2 | 2 | 1 | 1 | 0 | Upgrade
|
| Shares Change (YoY) | 190.11% | 5.11% | 90.11% | 103.90% | 117.10% | 146.00% | Upgrade
|
| EPS (Basic) | -3.26 | -6.35 | -9.68 | -8.25 | -38.55 | -132.16 | Upgrade
|
| EPS (Diluted) | -3.26 | -6.35 | -9.68 | -8.25 | -38.55 | -132.16 | Upgrade
|
| Free Cash Flow | -5.85 | -7.63 | -12.8 | -11.86 | -15.31 | 2.46 | Upgrade
|
| Free Cash Flow Per Share | -0.96 | -3.50 | -6.18 | -10.89 | -28.67 | 10.00 | Upgrade
|
| Gross Margin | 72.50% | 71.98% | 61.79% | 79.52% | 57.67% | 52.32% | Upgrade
|
| Operating Margin | -337.80% | -184.84% | -264.45% | -231.05% | -180.78% | -108.29% | Upgrade
|
| Profit Margin | -493.45% | -237.26% | -334.40% | -115.05% | -215.35% | -208.71% | Upgrade
|
| Free Cash Flow Margin | -145.37% | -130.99% | -213.57% | -151.86% | -160.15% | 15.80% | Upgrade
|
| EBITDA | -10.61 | -7.48 | -10.25 | -11.17 | -10.62 | -11.58 | Upgrade
|
| EBITDA Margin | -263.77% | -128.46% | -171.01% | -143.00% | -111.11% | -74.32% | Upgrade
|
| D&A For EBITDA | 2.98 | 3.28 | 5.6 | 6.88 | 6.66 | 5.29 | Upgrade
|
| EBIT | -13.59 | -10.76 | -15.85 | -18.05 | -17.28 | -16.87 | Upgrade
|
| EBIT Margin | - | -184.84% | -264.44% | -231.05% | -180.78% | -108.29% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.